Genematrix acquired a new product license from KFDA for multiplex molecular diagnosis of pneumonia causative virus 페이지 정보 작성일 19-04-03 00:00 목록 본문 . 관련링크 http://www.sisamagazine.co.kr/news/articleView.html?idxno=187035 644회 연결 Genematrix acquired a patent for proprietary technology for multiplex molecular diagnosis 19.04.05 Genematrix invested 5.7 billion won in British company, Vaccitech... “Investment for joint :new drug development cooperation” 18.12.20
ENG